Document Detail

Stent medicati per interventi su graft di vena safena.
MedLine Citation:
PMID:  21516072     Owner:  NLM     Status:  In-Data-Review    
Drug eluting stents (DES) have improved percutaneous coronary intervention (PCI) outcomes for most coronary lesion subsets and have gained widespread acceptance. This practice is supported by large-scale clinical trials. Evidence for DES use for treatment of saphenous vein graft (SVG) lesions is less well defined and often conflicting. Most SVG interventions are performed in the setting of an acute coronary syndrome (ACS), in large caliber vascular conduits with soft and friable plaque with inflammatory debris, without a fibrous cap. In this review, we provide an up to date assessment of the published evidence on DES use in PCI of SVG lesions.
S Banerjee; R Master; A Iqbal; E S Brilakis
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva cardioangiologica     Volume:  59     ISSN:  0026-4725     ISO Abbreviation:  Minerva Cardioangiol     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400725     Medline TA:  Minerva Cardioangiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  235-8     Citation Subset:  IM    
VA North Texas Healthcare System, Washington, DC, USA2 University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Primary PCI in STEMI - dilemmas and controversies: multivessel disease in STEMI patients. Complete v...
Next Document:  Update in cardiopulmonary resuscitation.